Interpretable machine learning-driven multi-omics risk stratification and drug repurposing nominates Treg/Th17 with gluconeogenesis/lactylation integration as a prognostic and druggable biomarker for glioblastoma patients.
Xie S, Chen W, Zhang B · Frontiers in oncology · 2026 · Article
10.3389/fonc.2026.1761182
Verified evidence
Network node removal
5b9caa07-8f04-5b7a-ac07-cdac5fe186c0Prediction source Version of record · PDF page(s) 11, 12
Study 8ad57a45-a171-5b66-8047-424e2cdca05a · Prediction record (JSON)